Login

Gianmarco Lanza, CEO of FAE Technology SB S.p.A., will be the guest speaker at the upcoming free Smart Webinar. 00:10:00

Share On Facebook Share On Twitter

Videointervista Gianmarco Lanza – CEO FAE Technology

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Global Economic Growth and Recovery Post-Pandemic: Insights from José Martinez Sangrenetti
00:10:00
I speak with RingCentral Founder Vlad Shmunis and CEO Tarek Robbiati about how the platform will differentiate itself in a crowded market.
00:10:00
Ben McMillan, CIO and founder of IDX Digital Assets, discusses market insights in an interview with CNBC.
00:10:00
Far Resources CEO Toby Mayo Discusses Canadian Lithium Projects in Manitoba and Northwest Territories
00:10:00
Kimpur CEO Cavidan Karaca Discusses the Company’s Growth and Future Outlook | Cavidan Karaca ,CEO , Kimpur.
00:10:00
Why Estate Planning is Essential for Everyone | Andrea M. Gray, VICE PRESIDENT, ESTATE STRATEGIES of Howe & Rusling, Inc.
00:10:00
Rebranding for the Future: Bernard Fick and Graham Mason on Becoming M&G Investments
00:00:00
Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:00:00
Anatara Lifesciences with Proactive at ASX Small and Mid-Cap Conference - Steve Lydeamore, CEO, Anatara Lifesciences Ltd
00:10:00
Fund established by operators for operators|Pascal Levy-Garboua,Venture Partner,Long Journey Ventures
00:10:00
Getty Images CEO Craig Peters discusses their vision for generative AI and its launch in an NYSE Floor Talk.
00:10:00
Iain Conn discusses CEO succession at Centrica in the interim financial report.

© 2017 - Neuhu+